Story on FDA authorizing new test kit for coronavirus withdrawn

FILE PHOTO: The spread of the coronavirus disease (COVID-19) in New York

(Reuters) - The March 31 story on BodySphere receiving FDA authorization for a rapid antibody test for coronavirus has been withdrawn. In a statement to Reuters, BodySphere said it has not received this authorization. There will be no replacement story.